1 / 2

Madhavbaug's PAT up 785 per cent in FY22

Madhavbaug's PAT up 785 per cent in FY22

AaliyaGoyel
Download Presentation

Madhavbaug's PAT up 785 per cent in FY22

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Downloaded from: justpaste.it/4vzjt Madhavbaug's PAT up 785 per cent in FY22 The company is planning to tie up with over 30 insurance company to its facilitate patients Madhavbaug, brand of Vaidya Sane Ayurved Laboratories Ltd, a specialist in treating and reversing cardiac related ailments through their Ayurvedic treatment and therapies, reported a whopping 785 per cent growth in net profit after tax (PAT) in FY2021-22 despite facing Covid related lockdowns in the initial few months. Madhavbaug’s net profit stood at Rs 3.46 crore in FY 22 as compared to Rs 39 lakhs in FY21. Madhavbaug, which operates 272 clinics and 2 hospitals spread across eight states in India saw its gross revenue increase to Rs 75.04 crore in FY22, a 43 per cent rise from Rs 52.37 crore in FY 21 while its EBIDTA grew 66 per cent from Rs 4.36 crore to Rs

  2. 7.25 crore during the same period. The robust all-round performance came on the back of solid double-digit growth witnessed across its treatment verticals amidst a surge in the number of patients seeking ayurvedic remedies underscoring the growing relevance, acceptability and efficacy of the traditional line of treatment….Read More

More Related